Cardiomuscular Biomarkers in the Diagnosis and Prognostication of Immune Checkpoint Inhibitor Myocarditis
Circulation · 08.08.2023 · 148 (6) · 473-486
DOI: 10.1161/circulationaha.123.062405 ↗Kurz gefasst
Fachartikel in der Zeitschrift Circulation, erschienen am 08.08.2023. Verfasst von Lorenz H Lehmann und 26 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Angiology, and Pneumology, Heidelberg University Hospital, German Centre for Cardiovascular Research DZHK, Heidelberg, Germ…. Hauptthemen laut MEDLINE: Myocarditis. Die Arbeit wurde bisher 172-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NHLBI NIH HHS.
Abstract (Originalsprache)
BACKGROUND: Immune checkpoint inhibitors (ICIs) are approved for multiple cancers but can result in ICI-associated myocarditis, an infrequent but life-threatening condition. Elevations in cardiac biomarkers, specifically troponin-I (cTnI), troponin-T (cTnT), and creatine kinase (CK), are used for diagnosis. However, the association between temporal elevations of these biomarkers with disease trajectory and outcomes has not been established. METHODS: We analyzed the diagnostic accuracy and prognostic performances of cTnI, cTnT, and CK in patients with ICI myocarditis (n=60) through 1-year follow-up in 2 cardio-oncology units (APHP Sorbonne, Paris, France and Heidelberg, Germany). A total of 1751 (1 cTnT assay type), 920 (4 cTnI assay types), and 1191 CK sampling time points were available. Major adverse cardiomyotoxic events (MACE) were defined as heart failure, ventricular arrhythmia, atrioventricular or sinus block requiring pacemaker, respiratory muscle failure requiring mechanical ventilation, and sudden cardiac death. Diagnostic performance of cTnI and cTnT was also assessed in an international ICI myocarditis registry. RESULTS: Within 72 hours of admission, cTnT, cTnI, and CK were increased compared with upper reference limits (URLs) in 56 of 57 (98%), 37 of 42 ([88%] P =0.03 versus cTnT), and 43 of 57 ([75%] P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, Angiology, and Pneumology, Heidelberg University Hospital, German Centre for Cardiovascular Research DZHK, Heidelberg, Germany (L.H.L., M.B.H., D.F., F.S., J.P.M., H.A.K., E.G., N.F., Z.K.).
- German Cancer Research Center (DKFZ), Heidelberg, Germany (L.H.L.).
- Sorbonne Université, Assistance Publique-Hôpitaux de Paris, INSERM, Department of Pharmacology, UNICO-GRECO Cardio-oncology program, Pitié-salpétrière Hospital, Paris, France (G.B., A.P., F.S., M.B., C.F., O.H., J-E.S.).
- University of California San Diego (J.R.P).
- Sorbonne Université, Assistance Publique-Hôpitaux de Paris, INSERM, Department of Cardiology, UNICO-GRECO Cardio-oncology program, Saint-Antoine Hospital, Paris, France (S.E.).
- Hopital Ambroise-Paré, Neuilly Sur Seine, France (E.F-B.).
ORCID-Profile: Lorenz H Lehmann, Markus B Heckmann, Daniel Finke, Adrien Procureur, John R Power, Stephane Ederhy, Elisa Funck-Brentano, Laurence Pieroni, Jan P Münster, Yves Allenbach, Nicolas L Palaskas, Salim S Hayek, Evangelos Giannitsis, Ziya Kaya, Javid Moslehi, Edi Prifti, Joe-Elie Salem
Förderung
- NCI NIH HHS
- NHLBI NIH HHS
Zitieren
APA
Lehmann, L. H., Heckmann, M. B., Bailly, G., Finke, D., Procureur, A., Power, J. R., Stein, F., Bretagne, M., Ederhy, S., Fenioux, C., Hamwy, O., Funck-Brentano, E., Romano, E., Pieroni, L., Münster, J. P., Allenbach, Y., Anquetil, C., Leonard-Louis, S., Palaskas, N. L., …, & Salem, J. E. (2023). Cardiomuscular Biomarkers in the Diagnosis and Prognostication of Immune Checkpoint Inhibitor Myocarditis. Circulation, 148(6), 473-486. https://doi.org/10.1161/circulationaha.123.062405
Vancouver
Lehmann LH, Heckmann MB, Bailly G, Finke D, Procureur A, Power JR, et al. Cardiomuscular Biomarkers in the Diagnosis and Prognostication of Immune Checkpoint Inhibitor Myocarditis. Circulation. 2023;148(6):473-486. doi:10.1161/circulationaha.123.062405
BibTeX
@article{Lehmann2023,
author = {Lehmann, Lorenz H and Heckmann, Markus B and Bailly, Guillaume and Finke, Daniel and Procureur, Adrien and Power, John R and Stein, Frederic and Bretagne, Marie and Ederhy, Stephane and Fenioux, Charlotte and Hamwy, Omar and Funck-Brentano, Elisa and Romano, Emanuela and Pieroni, Laurence and Münster, Jan P and Allenbach, Yves and Anquetil, Céline and Leonard-Louis, Sarah and Palaskas, Nicolas L and Hayek, Salim S and Katus, Hugo A and Giannitsis, Evangelos and Frey, Norbert and Kaya, Ziya and Moslehi, Javid and Prifti, Edi and Salem, Joe-Elie},
title = {Cardiomuscular Biomarkers in the Diagnosis and Prognostication of Immune Checkpoint Inhibitor Myocarditis},
journal = {Circulation},
year = {2023},
volume = {148},
number = {6},
pages = {473--486},
doi = {10.1161/circulationaha.123.062405}
}
EUVIMED